• Journal: American Journal of Preventive Cardiology
Clear all

Evidence-based SGLT2 inhibitor and GLP-1 receptor agonist use by race in the VA healthcare system

Abstract: Importance: Adoption of novel therapeutics often lags for Black versus non-Hispanic White patients. Seminal clinical trials established the cardiovascular efficacy of …

Blood pressure control among Veterans with high cardiovascular disease risk

Abstract: Objective: Blood pressure (BP) control reduces risk of cardiovascular disease (CVD), the major cause of disability and mortality among the nine million U.S. Veterans …

Haptoglobin phenotype and intensive glycemic control for coronary artery disease risk reduction in people with type two diabetes: The Veterans Affairs Diabetes Trial

Abstract: Background: Intensive glycemic control reduced the risk of coronary artery disease (CAD) events among White ACCORD study participants with the haptoglobin (Hp)2-2 …